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A n application o f magnetic resonance imaging in the field o f  pharma­
ceutical technology is presented in this paper. The analysis o f diffusion and 
swelling fronts was carried out for four floating dosage forms using magnetic 
resonance imaging. The influence o f polymer viscosity, its concentration, 




Floating systems could be useful for controlled delivery of drugs which act 
locally in the stomach or have a narrow absorption window in the proximal part 
of the gastrointestinal tract. Among the floating systems hydrodynamically bal­
anced systems (HBS) are the only commercially available formulations. HBS are 
essentially composed of a drug intimately mixed with gel forming hydrocolloids, 
which swell in contact with gastric fluid. The hydrogel shell maintains a relative 
integrity of shape and has a bulk density smaller than 1 g /cm 3. The drug is slowly 
released in the stomach by diffusion through the hydrogel barrier and erosion of 
the surface of the dosage form.
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In the hydrophilic matrices, drug release is determined by swelling and ero­
sion of the polymer matrix and dissolution of the drug. The kinetics of these 
phenomena can be analysed by the observing of the motion of swelling and diffu­
sion fronts within the matrix. The positions of the diffusion and swelling fronts 
define the hydrogel layer thickness. This is the fundamental factor which controls 
drug release from the dosage form. The position of the swelling front defines the 
border of the inner dry core which controls the flotation of the HBS formulation.
The aim of this work was to determine how viscosity and concentration of 
the polymer and the applied dissolution medium affect the position of the fronts 
in the gel layer of HBS.
2. Materials
Hypromellose (HPMC) is a partly O-methylated and O-(2-hydroxy- 
propylated) cellulose widely used in pharmaceutical technology. In this study 
HPMC with two viscosities 400 cP and 100 000 cP were used. The model drug 
employed was L-dopa. White opaque hard gelatin capsules Coni-Snap® size 1 
and 0 were used. All reagents were in at least p.p.a. grade. Mixtures of L-dopa 
and HPMC in the ratios 1:1 and 1:3 were prepared in the mortar. Capsules were 
filled manually with non-compressed powder mixtures corresponding to 100 mg of 
L-dopa.
For swelling studies two kinds of media were used: fasted state simulated 
gastric fluid (FaSSGF) —  hydrochloric acid 0.1 M and fed state simulated gastric 
fluid (FeSSGF) —  hydrochloric acid 0.01 M with addition of sodium laurylsulphate 
(2.5 g /l) and sodium chloride (2.0 g /l).
In this study the following cases were analyzed:
• metolose 100000 cP +  L-dopa (3+1) in FaSSGF,
• metolose 100000 cP +  L-dopa (3+1) in FeSSGF,
• metolose 100000 cP +  L-dopa (1+1) in FeSSGF,
• metolose 400 cP +  L-dopa (3+1) in FeSSGF.
3. Methods
The magnetic resonance imaging (MRI) studies were done with a research 
MRI system consisting of a digital console MARAN DRX and a 4.7 T/310 mm 
horizontal bore superconducting magnet equipped with an actively shielded gra­
dient set of 200 mm ID [1]. A specially designed, MR compatible, flow-through 
cell combined with MRI probe-head for HBS systems investigation was used [2]. 
In the cell the HBS capsule was kept in a horizontal position in the centre of the 
RF coil, and was oriented along the direction of B 0 field. The experiments were 
carried out under continuous flow in two dissolution media, FaSSGF and FeSSGF.
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MR images were obtained every half an hour with a flow compensated spin-echo 
(SE) pulse sequence to avoid effects of flowing solvent in MR images. Back-to­
-back bipolar gradient wave forms (shaded areas in Fig. 1) were used in velocity 
insensitive SE sequence for gradient first moment nulling [3]. Single experiment 
lasted for 5 hours.
Fig. 1. Flow compensated spin-echo M RI pulse sequence (RF —  n  and n / 2  radio 
frequency pulses; ACQ  —  acquired M R signal; G x , G y , G z  —  magnetic field gradient 
pulses in x ,  y , z  directions, respectively; TE  —  echo time).
Areas of different HBS sections, i.e. hydrogel, dry core were measured in 
MR images with the “ImageJ” software (NIH, Bethesda, MD, USA).
4. Results
The formation of moving fronts was imaged in this study by MRI. 
Figure 2 shows examples of the identification moving front for HPMC 100000 cP 
and L-dopa mixed in a 3:1 ratio in FeSSGF after 5 hours.
A comparative analysis of the images shows that the mechanism of water 
penetration into the polymer matrix is related to viscosity of the polymer and 
its concentration in the dosage form. The MR images of HBS show not only the 
general shape of the capsule but also its structural characteristics.
In the case of HBS containing HPMC 100000 cP and L-dopa in 3:1 ratio in 
FaSSGF, a rapid increase in the area of the diffusion front was observed in the 
images upon placement in the solvent (see Fig. 3). The area of the diffusion front 
increased from 500 pixels after 60 minutes to almost 2000 pixels after 90 minutes. 
For the following 4 hours the area of the diffusion front remained nearly constant. 
In the other cases the area of diffusion fronts increased gradually during five hours.
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Fig. 2. Examples of the identification o f moving fronts: (A ) original image, (B) diffusion 
front, (C ) swelling front, (D) dry core.
Fig. 3. Profiles o f changes o f areas o f diffusion fronts: A  metolose 400 cP +
L-dopa (3+ 1) in FeSSGF, •  metolose 100000 cP +  L-dopa (1+ 1) in FeSSGF, ■ meto­
lose 100000 cP  +  L-dopa (3+ 1) in FaSSGF, ♦  metolose 100000 cP +  L-dopa (3+1) in 
FeSSGF.
The areas of the swelling fronts increased gradually in all cases (Fig. 4). The 
fastest formation of the swelling front in the early stages of hydrogel formation 
was observed for HBS containing the mixture of HPMC 400 cP and L-dopa in a 
3:1 ratio in FeSSGF. After 30 minutes the area of the swelling front was 838 pixels 
and after 300 minutes it has grown to about 1300 pixels. In the case of a HBS 
containing mixture of HPMC 100000 cP and L-dopa in a 3:1 ratio in FaSSGF, the
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Fig. 4. Profiles o f changes o f areas o f swelling fronts: A  metolose 400 cP +  L-dopa 
(3+1) in FeSSGF, •  metolose 100000 cP +  L-dopa (1+1) in FeSSGF, ■ metolose 
100000 cP +  L-dopa (3+1) in FaSSGF, ♦  metolose 100000 cP +  L-dopa (3+ 1 ) in 
FeSSGF.
increase in the swelling front in the end of experiment was most effective. The area 
of swelling front increased by a factor of 3.5 during five hours. These observations 
suggest that the dissolution of the active substance and the floating properties of 
the HBS formulations depend on the type of the dissolution medium (FeSSGF or 
FaSSGF) and the concentration of the polymer in the dosage form.
An analysis of the dry cores of the HBS have shown that their areas were 
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Fig. 5. Profiles o f changes o f  areas o f  dry cores: A  metolose 400 cP +  L-dopa (3+1) 
in FeSSGF, •  metolose 100000 cP +  L-dopa (1+1) in FeSSGF, ■ metolose 100000 cP  +  
L-dopa (3+1) in FaSSGF, ♦  metolose 100000 cP +  L-dopa (3+1) in FeSSGF.
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Swelling and diffusion front area profiles in the hydrogel matrix and dry core 
area profiles can be used to describe the integrity of the HBS as well as the swelling 
properties of the dosage forms.
Observations of increasing areas of the swelling and diffusion fronts and al­
most constant areas of dry cores between 30 and 300 min after capsule immersion 
suggest that the dimensional changes of the HBS displace the molecules in the 
matrix due to expansion of polymeric chains [4, 5]. Moreover, the area of diffu­
sion front is almost constant between 90 and 210 min after capsule immersion. In 
the same time area of swelling front increases. In other words, area between the 
swelling and diffusion fronts decreases. It suggests that the process of hydrogel 
erosion takes place. It means that during hydration of the HBS under the contin­
uous medium flow two opposite processes take place: the swelling of the polymer 
matrix and the erosion of the outer layer of the hydrogel. The appropriate bal­
ance between swelling and erosion processes might effectively control the floating 
properties of HBS and dissolution of the active substance.
Erosion of hydrogel should be confirmed using other methods used in phar­
maceutical sciences.
5. Conclusions
1. Moving fronts can be observed with MRI.
2. The rate of swelling of uncompressed HPMC matrices depends on the type 
o f medium, concentration of the polymer in the dosage form and the viscosity of 
the polymer.
3. The dissolution of L-dopa (which is soluble in water) depends mainly on 
the diffusion of the dissolved drug in the polymer matrix.
4. The erosion of the matrix is an additional mechanism influencing the 
dissolution of the drug.
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